MARTIGNANI, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 8.552
EU - Europa 7.674
AS - Asia 3.947
AF - Africa 466
SA - Sud America 19
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.677
Nazione #
US - Stati Uniti d'America 8.538
GB - Regno Unito 2.139
IT - Italia 1.731
CN - Cina 1.246
VN - Vietnam 1.214
DE - Germania 1.007
SG - Singapore 936
UA - Ucraina 708
SE - Svezia 668
IN - India 387
RU - Federazione Russa 326
FR - Francia 318
IE - Irlanda 275
EE - Estonia 178
CI - Costa d'Avorio 143
ZA - Sudafrica 126
FI - Finlandia 90
TG - Togo 85
SC - Seychelles 67
CH - Svizzera 61
BG - Bulgaria 56
JO - Giordania 48
NG - Nigeria 38
BE - Belgio 30
IR - Iran 28
JP - Giappone 23
GR - Grecia 20
NL - Olanda 17
KR - Corea 15
AU - Australia 13
CA - Canada 12
HK - Hong Kong 11
RO - Romania 11
CL - Cile 9
PL - Polonia 7
BR - Brasile 6
BD - Bangladesh 5
EG - Egitto 5
ID - Indonesia 5
LB - Libano 5
AR - Argentina 4
AT - Austria 4
CZ - Repubblica Ceca 4
LT - Lituania 4
TH - Thailandia 4
TR - Turchia 4
UZ - Uzbekistan 4
ES - Italia 3
EU - Europa 3
KZ - Kazakistan 3
NO - Norvegia 3
RS - Serbia 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HR - Croazia 2
HU - Ungheria 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BZ - Belize 1
DK - Danimarca 1
HT - Haiti 1
IQ - Iraq 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 20.677
Città #
Southend 1.919
Fairfield 954
Singapore 851
Ashburn 752
Chandler 632
Jacksonville 522
Wilmington 493
Santa Clara 474
Dong Ket 449
Woodbridge 444
Princeton 442
Seattle 442
Houston 420
Cambridge 310
Ann Arbor 285
Dublin 275
Boardman 260
Westminster 201
Padova 198
Nanjing 193
Abidjan 143
Bologna 140
Berlin 121
Milan 120
Saint Petersburg 112
Medford 100
Shenyang 98
Bremen 92
Jinan 90
Lomé 85
Helsinki 83
Rome 83
Mülheim 82
Changsha 77
New York 74
Beijing 73
San Diego 68
Mahé 67
Turin 64
Nanchang 62
Sofia 56
Hebei 53
Amman 48
Bern 43
Des Moines 43
Olalla 43
Jiaxing 42
Abeokuta 38
Guangzhou 37
Tianjin 34
Verona 34
Bari 33
Zhengzhou 32
Ningbo 31
Brussels 29
Hangzhou 28
Shanghai 28
Norwalk 23
Tokyo 23
Haikou 22
Mountain View 22
Dearborn 21
Taizhou 21
Lanzhou 19
Falls Church 18
Florence 18
Los Angeles 16
Bühl 15
Monmouth Junction 15
Chengdu 14
Monterotondo 14
Pune 14
Ardabil 13
Kunming 13
London 13
Paris 13
Phoenix 13
Naples 12
Taiyuan 12
Chicago 11
Messina 11
Palermo 11
San Venanzo 11
Fuzhou 10
Hyderabad 10
Redwood City 10
Costa Mesa 9
Hong Kong 9
Leawood 9
Augusta 8
Falkenstein 8
Hefei 8
Boydton 7
Catania 7
Chongqing 7
Frankfurt am Main 7
Kuban 7
Lappeenranta 7
Moscow 7
Redmond 7
Totale 13.547
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 803
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 223
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 191
Aritimie cardiache, morte cardiaca improvvisa, sincope 184
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 182
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 170
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 160
AF burden is important - Fact or fiction? 159
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 155
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 154
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 152
Atrial fibrillation ablation: beyond electro-mechanical matters 149
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 148
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 147
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 144
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 141
Electrocardiographic remodeling during cardiac resynchronization therapy 137
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 135
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 133
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 132
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 131
Atrial fibrillation and heart failure: does one epidemic feed he other? 131
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 131
Rate control in AFFIRM: considerations about the clinical implications. 130
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 130
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 130
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 128
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 128
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 127
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 127
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 127
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 126
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 125
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 124
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 124
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 123
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 122
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 122
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 122
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 121
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 118
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 117
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 116
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 116
Cardiac resynchronization by pacing: an electrical treatment of heart failure 116
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 115
A plateau waveform shape allows a much higher patient shock energy tolerance 115
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 115
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 114
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 113
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 113
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 113
Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. 112
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 112
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 112
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 111
Poor Glycaemic Control and Arrhythmias. 111
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 111
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 110
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 110
Role of drugs and devices in patients at risk of sudden cardiac death. 110
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 109
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 109
Cardiac resynchronization therapy: a cost or an investment? 109
Implantation of cardioverter-defibrillator: Effects on shoulder function. 109
Cardioversione elettrica associata ad impianto di dispositivo per resincronizzazione cardiaca: quali risultati a distanza? 109
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 109
The QRS interval in patients treated with resynchronization therapy: which value 108
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 108
Cardioversione elettrica di fibrillazione e flutter atriale: risultati a distanza. 107
Is ventricular sensing always right, when it is left? 107
Cardiac resynchronisation therapy: effect on intra-ventricular and inter-ventricular dyssynchrony at radionuclide angiography by Fourier phase analysis 106
Cardiac resynchronization therapy: update on clinical studies 106
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 105
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 105
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 105
Clinical and therapeutic implications of troponin elevation in cardiac arrest 105
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 104
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 103
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 103
Phrenic stimulation: a challenge for cardiac resynchronization therapy 103
Is cardiac resynchronization therapy cost-effective? 102
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 102
A plateau waveform shape allows a much higher patient shock energy tolerance. Poster 2872 102
Contribution of morphology discrimination algorithm for improving rhythm discrimination in slow and fast ventricular tachycardia zones in dual-chamber implantable cardioverter-defibrillators. 101
The challenge of preventing stroke in elderly patients with atrial fibrillation. 101
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. 100
Persistenza della vena cava superiore sinistra in candidati a pacemaker o cardioverter-defibrillatore: implicazioni pratico-cliniche. 100
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. 99
Mechanisms of pain associated with internal defibrillation shocks: results of a randomized study of shock waveform. 99
Predictors of long-term survival free from relapses after extraction of infected CIED. 99
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 99
Primary Prevention of Sudden Cardiac Death: Can We Afford the Cost of Cardioverter-Defibrillators? Data from the Search-MI Registry-Italian Sub-study 97
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 97
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 97
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. 96
Single versus dual-chamber ICDs : evaluation of rhythm discrimination QRS morphology. 95
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 95
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 95
Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children. 94
Totale 12.707
Categoria #
all - tutte 49.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.967 0 0 0 0 0 461 509 601 540 323 180 353
2020/20213.203 611 192 67 158 31 140 35 160 217 155 134 1.303
2021/20223.403 334 173 219 292 326 228 48 271 104 154 607 647
2022/20233.769 365 452 189 501 217 221 115 196 666 218 319 310
2023/20241.162 93 178 88 79 119 228 83 75 62 58 40 59
2024/20252.600 189 797 318 312 801 183 0 0 0 0 0 0
Totale 21.081